Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Reinhard Dummer

Reinhard Dummer


Dept. Of Dermatology
University Hospital Zürich

Professor Reinhard Dummer is Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland and is a key thought leader in worldwide cutaneous oncology. Currently he is heading of the Skin Cancer Unit and the Clinical Trial Unit of the Department of Dermatology.

Professor Dummer began his medical education in haematology and oncology before successfully completing his dermatology residency in Würzburg, Germany, and Zürich in 1992.

He is Board Certified in allergology, clinical immunology, dermatology and dermatopathology.

Professor Dummer’s principal research interests are molecular biology, immunology and immunotherapy of cutaneous malignancies, including cutaneous lymphomas and melanomas. He has published more than 677 papers with a cumulative impact factor of more than 5787. He was past-president of the Melanoma Project Group of the Swiss Institute for Applied Cancer Research,1999 -2016, is a member of German National Academy of Sciences (Leopoldina) and is a past board member of the Society for Melanoma Research and past President of the International Society for Cutaneous Lymphomas.

He is a founding and board member of the European Association of Dermato-Oncology (EADO), ESMO, EATI, URPP and past President of the European Society for Dermatological Research (ESDR).

Professor Dummer has been a member of the ESMO Open Editorial Board since 2016, and of the Cancer Research ESMO Faculty Group since 2015.

He was also an ESMO Faculty member for Cutaneous T-Cell Lymphoma, 2006-2008; coordinator of the ESMO Faculty for Melanoma, 2012-2016; and member of the ESMO Educational Committee, 2012-2016.

ESMO 2017 Congress

"The Melanoma and Other Skin Tumours Track will present melanoma as the paradigm for modern tumour therapy. Progress is based on basic and translational research, which is more intensive than ever before. Additional progressions are also expected to have an impact on the treatment strategies for other malignancies."

Reinhard Dummer


Reinhard Dummer was the Melanoma and Other Skin Tumours Track Chair of the ESMO 2017 Congress, which took place in Madrid, Spain (8-12 September 2017).

View ESMO 2017 Congress meeting resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.